Cargando…

Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies

BACKGROUND: Case reports, retrospective analyses, and observational studies have linked the use of cisplatin to increased risk of second cancers, especially life-threatening secondary leukemia. We therefore performed a systematic review and meta-analysis to evaluate the risk of second cancers associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Fei, Zhang, Sheng, Xue, Hongxi, Chen, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738212/ https://www.ncbi.nlm.nih.gov/pubmed/29258467 http://dx.doi.org/10.1186/s12885-017-3902-4

Ejemplares similares

Comparison of primary endpoints between publications, registries, and protocols of phase III cancer clinical trials
por: Liang, Fei, et al.
Publicado: (2017)

Risk of second primary cancer among breast cancer patients: A systematic review and meta-analysis
por: Parhizgar, Parynaz, et al.
Publicado: (2023)

Risk of extracolonic second primary cancers following a primary colorectal cancer: a systematic review and meta-analysis
por: Robertson, Dylan, et al.
Publicado: (2022)

The risk of second primary cancer after nasopharyngeal cancer: a systematic review
por: Svärd, Fanni, et al.
Publicado: (2023)

Risk of developing a second primary cancer in male breast cancer survivors: a systematic review and meta-analysis
por: Allen, Isaac, et al.
Publicado: (2022)

Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy
por: Zhang, Bo, et al.
Publicado: (2020)

The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era
por: Jahreiß, Marie-Christina, et al.
Publicado: (2020)

Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis
por: Allen, Isaac, et al.
Publicado: (2023)

Cisplatin or Not in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
por: Petrelli, Fausto, et al.
Publicado: (2013)

Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy
por: Ng, Sweet Ping, et al.
Publicado: (2019)

Risk of second primary cancer in men with breast cancer
por: Satram-Hoang, Sacha, et al.
Publicado: (2007)

Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) as secondline therapy for patients with advanced urothelial cancer
por: Zhang, Sheng, et al.
Publicado: (2016)

Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer
por: Zheng, Guoqiao, et al.
Publicado: (2021)

Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers
por: Zheng, Guoqiao, et al.
Publicado: (2021)

Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis
por: Li, Bo, et al.
Publicado: (2019)

Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer
por: Kim, Eric S., et al.
Publicado: (2017)

Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study
por: Ruan, Xiaohao, et al.
Publicado: (2023)

Prostate cancer survivors: Risk and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Risk of Second Primary Thyroid Cancer in Women with Breast Cancer
por: Cieszyńska, Monika, et al.
Publicado: (2022)

Single nucleotide polymorphisms and the risk of developing a second primary cancer among head and neck cancer patients: a systematic literature review and meta-analysis
por: Hoxhaj, Ilda, et al.
Publicado: (2021)

Prognostic outcome after second primary lung cancer in patients with previously treated lung cancer by radiotherapy
por: Wu, Yijun, et al.
Publicado: (2020)

Novel mutations in a second primary gastric cancer in a patient treated for primary colon cancer
por: Purwar, Roli, et al.
Publicado: (2023)

Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer
por: Consorti, Fabrizio, et al.
Publicado: (2011)

Second primary cancers of the breast: incidence and risk factors.
por: Hislop, T. G., et al.
Publicado: (1984)

Familial Risks and Mortality in Second Primary Cancers in Melanoma
por: Chattopadhyay, Subhayan, et al.
Publicado: (2019)

Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers
por: Zheng, Guoqiao, et al.
Publicado: (2021)

Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer
Publicado: (2018)

Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party
por: Berghmans, T, et al.
Publicado: (2007)

Familial risks of second primary cancers and mortality in ovarian cancer patients
por: Zheng, Guoqiao, et al.
Publicado: (2018)

Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis
por: Zhao, Jie, et al.
Publicado: (2023)

Comparative efficacy of second-generation androgen receptor inhibitors for treating prostate cancer: A systematic review and network meta-analysis
por: Chen, Xiangyu, et al.
Publicado: (2023)

Risk of second primary lung cancer in patients with thyroid cancer: a meta-analysis based on big population studies
por: Wang, Haoyu, et al.
Publicado: (2023)

Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil
por: Ohkura, Yu, et al.
Publicado: (2019)

Vaginal vault carcinoma as second primary in a treated case of ovarian cancer
por: Shrivastava, Sushruta, et al.
Publicado: (2012)

Cancer Risk in Hashimoto’s Thyroiditis: a Systematic Review and Meta-Analysis
por: Hu, Xiaojie, et al.
Publicado: (2022)

Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis
por: Wallis, Christopher J D, et al.
Publicado: (2016)

The effect of patient characteristics on second primary cancer risk in France
por: Jégu, Jérémie, et al.
Publicado: (2014)

Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies
por: Zahnreich, Sebastian, et al.
Publicado: (2021)

Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
por: Sohn, Won, et al.
Publicado: (2021)

Meta-Analysis and Systematic Review in Environmental Tobacco Smoke Risk of Female Lung Cancer by Research Type
por: Ni, Xue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_am447vdoil5nqau97kkde2tapf